Skip to main content

ORTHOPEDIATRICS CORP

For the period ended Mar 31, 2025. Filed May 8, 2025.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2025 · Filed May 8, 2025

KIDS$33.48-1.5%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Condensed Consolidated Balance Sheets - March, 202 and December 31,

CONDENSED CONSOLIDATED BALANCE SHEETS

March 31, 2025December 31, 2024
ASSETS
Current assets:
Cash$33,439$43,820
Restricted cash1,9901,957
Short-term investments25,33325,013
Accounts receivable - trade, net of allowances of $1,242 and $1,145, respectively43,99342,357
Inventories, net119,752117,005
Prepaid expenses and other current assets7,5527,021
Total current assets232,059237,173
Property and equipment, net52,62250,596
Other assets:
Amortizable intangible assets, net62,34864,427
Goodwill93,67393,844
Other intangible assets16,73616,752
Other non-current assets12,81210,417
Total other assets185,569185,440
Total assets$470,250$473,209
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
Accounts payable - trade$14,199$8,908
Accrued compensation and benefits11,32513,888
Current portion of long-term debt with affiliate162160
Current portion of acquisition installment payable1,3681,347
Other current liabilities10,4519,659
Total current liabilities37,50533,962
Long-term liabilities:
Long-term term loan24,01323,957
Long-term convertible note48,04047,913
Long-term debt with affiliate, net of current portion410451
Other long-term debt, net of current portion563635
Acquisition installment payable, net of current portion2,4932,452
Deferred income taxes3,3893,381
Other long-term liabilities6,6915,892
Total long-term liabilities85,59984,681
Total liabilities123,104118,643
Stockholders' equity:
Common stock, $0.00025 par value; 50,000,000 shares authorized; 24,827,977 shares and 24,217,508 shares issued as of March 31, 2025 and December 31, 2024, respectively66
Additional paid-in capital604,989600,897
Accumulated deficit(246,223)(235,564)
Accumulated other comprehensive loss(11,626)(10,773)
Total stockholders' equity347,146354,566
Total liabilities and stockholders' equity$470,250$473,209
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.